Skip to Main Content

Author Details

Zsofia Kote-Jarai
The Institute of Cancer Research
1988
200
60
PMIDPaper TitleJournal TitlePublished Year
36018819Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.Hum Mol Genet2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37612283Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.Nat Commun2023
37733366Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.JAMA Oncol2023
37932350Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer.Sci Rep2023
37025481Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variants.BJUI Compass2023
37311464Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.Am J Hum Genet2023
37292833Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry.medRxiv2023
36872133Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.Eur Urol2023
36528478Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.Eur Urol2023
36493335CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.J Clin Oncol2023
36629487RE: Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.J Natl Cancer Inst2023
34214236The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.BJU Int2022
35659150Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study.Eur Urol2022
35152271Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.Prostate Cancer Prostatic Dis2022
35031163A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.Eur Urol2022
34903604Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk.Cancer Res2022
34923574Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.Br J Cancer2022
34127801Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24.Prostate Cancer Prostatic Dis2022
32930425African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer.Int J Cancer2021
33623038Polygenic hazard score is associated with prostate cancer in multi-ethnic populations.Nat Commun2021
33673083Identification of Germline Genetic Variants that Increase Prostate Cancer Risk and Influence Development of Aggressive Disease.Cancers (Basel)2021
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
33941403Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.Eur Urol2021
34275018Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium.Eur J Epidemiol2021
34355204Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals.HGG Adv2021
33436325Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study.Eur Urol Oncol2021
33249427FRMD6 has tumor suppressor functions in prostate cancer.Oncogene2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33420416Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.Prostate Cancer Prostatic Dis2021
32800727Two-stage Study of Familial Prostate Cancer by Whole-exome Sequencing and Custom Capture Identifies 10 Novel Genes Associated with the Risk of Prostate Cancer.Eur Urol2021
32853339Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.J Natl Cancer Inst2021
32514134The effect of sample size on polygenic hazard models for prostate cancer.Eur J Hum Genet2020
35050761Genomic Profiles of De Novo High- and Low-Volume Metastatic Prostate Cancer: Results From a 2-Stage Feasibility and Prevalence Study in the STAMPEDE Trial.JCO Precis Oncol2020
31776447Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT.Prostate Cancer Prostatic Dis2020
33158149The <i>CHEK2</i> Variant C.349A&gt;G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.Cancers (Basel)2020
32941451Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study.PLoS One2020
32620889Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers.Nat Commun2020
32409115A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.Eur Urol2020
30527799Homeobox B13 G84E Mutation and Prostate Cancer Risk.Eur Urol2019
31860675Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.PLoS Med2019
31548585Publisher Correction: Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
31337649Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.Cancer Res2019
31537406Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.Eur Urol2019
31101764Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants.Cancer Res2019
30777372Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.Eur Urol2019
30837682Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.Br J Cancer2019
30683880Shared heritability and functional enrichment across six solid cancers.Nat Commun2019
30622367Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.Nat Genet2019
  • 1 - 50 of 200

Recommended Authors

Xiaoyu Wang
Fred Hutchison Cancer Center
Career Start Year 2015
Number of shared co-authors 17
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 26
Kristina M Jordahl
University of Washington
Career Start Year 2014
Number of shared co-authors 25
Aurelie Vogt
Frederick National Laboratory for Cancer Research (FNLCR), Inc.
Career Start Year 2012
Number of shared co-authors 22
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 36
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 15
Claire Palles
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2006
Number of shared co-authors 56
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 10
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 46
Mine S Cicek
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 84
Gong-Hong Wei
Fudan University Shanghai Cancer
Career Start Year 2004
Number of shared co-authors 13
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 10
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 27
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 22
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 18
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 56
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 11
Xiaoqing Chen
QIMR Berghofer Medical Research Institute
Career Start Year 1999
Number of shared co-authors 113
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 36
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 15
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 14
John V Pearson
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 52
Liang Wang
H. Lee Moffitt Cancer Center
Career Start Year 1996
Number of shared co-authors 27
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 38
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 37
Kathleen E Houlahan
University of California los angeles
Career Start Year 1991
Number of shared co-authors 22
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 25
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 26
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 61
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 24

Collaborators

Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 174
Douglas F Easton
University of Cambridge
Co-authored papers 129
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 70
Christopher A Haiman
University of Southern California
Co-authored papers 66
Fredrik Wiklund
Co-authored papers 61
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 59
Graham G Giles
Co-authored papers 58
Freddie C Hamdy
University of Oxford
Co-authored papers 58
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 58
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 53
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 48
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 46
Tokhir Dadaev
The Institute of Cancer Research
Co-authored papers 45
Ruth C Travis
Co-authored papers 43
Børge G Nordestgaard
Co-authored papers 42
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers 42
Sonja I Berndt
Co-authored papers 37
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 36
Kay-Tee Khaw
Co-authored papers 35
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 34
David V Conti
Co-authored papers 31
Daniel J Schaid
Mayo Clinic
Co-authored papers 31
Fredrick R Schumacher
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Co-authored papers 31
Judith A Clements
Co-authored papers 30
Sue A Ingles
Co-authored papers 29
William J Blot
Vanderbilt University Medical Center
Co-authored papers 29
Esther M John
Co-authored papers 28
Peter Kraft
Harvard T. H. Chan School of Public Health
Co-authored papers 28
Demetrius Albanes
Co-authored papers 27
Brian E Henderson
University of Southern California
Co-authored papers 27
Release 1.2